-
Velpatasvir is an NS5A
inhibitor (by Gilead)
which is used
together with
sofosbuvir in the
treatment of
hepatitis C
infection of all six
major genotypes...
- Sofosbuvir/
velpatasvir, sold
under the
brand name
Epclusa among others, is a fixed-dose
combination medication for the
treatment of
hepatitis C in adults...
- Sofosbuvir/
velpatasvir/voxilaprevir, sold
under the
brand name Vosevi, is a fixed-dose
combination medication for the
treatment of hepatitis C. It contains...
- or 12 w****s of sofosbuvir/
velpatasvir, or if
certain antiviral mutations are present, 12 w****s of sofosbuvir/
velpatasvir/voxilaprevir (when
certain antiviral...
- (glecaprevir + pibrentasvir)
Ravidasvir Sofosbuvir Sofosbuvir/
velpatasvir (sofosbuvir +
velpatasvir) Ledipasvir/sofosbuvir (ledipasvir + sofosbuvir) Ribavirin...
- J05AP54
Elbasvir and
grazoprevir J05AP55
Sofosbuvir and
velpatasvir J05AP56 Sofosbuvir,
velpatasvir and
voxilaprevir J05AP57
Glecaprevir and pibrentasvir...
-
first generics. The company's
commercially available products include velpatasvir/sofosbuvir, sofosbuvir/daclatasvir, osimertinib, crizotinib, daclatasvir...
-
inhibitor (by Gilead) that is used in
combination with
sofosbuvir and
velpatasvir. The
combination has the
trade name
Vosevi and
received a
positive opinion...
- part of some second-line treatments.
Sofosbuvir in
combination with
velpatasvir is
recommended for all
genotypes with a cure rate
greater than 90%, and...
- (sofosbuvir and ledipasvir)
Epclusa (sofosbuvir and
velpatasvir)
Vosevi (sofosbuvir,
velpatasvir, and voxilaprevir)
Zepatier (elbasvir and grazoprevir)...
